Inovio Pharmaceuticals

INONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$69.022 M

$0.67 -0.86%

Close of 7 Aug 2026

Revenue

$65.3K

#3623 by revenue

Earnings

-$85.0M

Loss-making

Shares outstanding

69,091,956

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#332Rein TherapeuticsRNTX$69.9M
#333XBiotechXBIT$69.2M
#334Inovio PharmaceuticalsINO$69.0M
#335Nomad Power SolutionsNMAD$68.3M
#336CleneCLNN$67.5M

Where these numbers come from

Share counts and financials for Inovio Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.